Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Result Filters

J Biomol Screen. 2008 Apr;13(4):285-94. Epub 2008 Mar 18.

A profiling platform for the identification of selective metalloprotease inhibitors.

Antczak C, Radu C, Djaballah H.

Source

High Throughput Screening Core Facility Molecular Pharmacology and Chemistry Program Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York 10065, USA.

Abstract

Although proteases represent an estimated 5% to 10% of potential drug targets, inhibitors for metalloproteases (MPs) account for only a small proportion of all approved drugs, failures of which have typically been associated with lack of selectivity. In this study, the authors describe a novel and universal binding assay based on an actinonin derivative and show its binding activities for several MPs and its lack of activity toward all the non-MPs tested. This newly developed assay would allow for the rapid screening for inhibitors of a given MP and for the selectivity profiling of the resulting hits. The assay has successfully enabled for the first time simultaneous profiling of 8 well-known inhibitors against a panel of selected MPs. Previously published activities for these inhibitors were confirmed, and the authors have also discovered new molecular targets for some of them. The authors conclude that their profiling platform provides a generic assay solution for the identification of novel metalloprotease inhibitors as well as their selectivity profiling using a simple and homogeneous assay.

PMID:: 18349423; [PubMed - indexed for MEDLINE]
PMCID:: PMC2365505

Free PMC Article

Images from this publication.See all images (5) Free text

FIG. 1

FIG. 3

FIG. 5

FIG. 2

FIG. 4

LinkOut - more resources

Full Text Sources

Supplemental Content

Icon for HighWire Press

Icon for PubMed Central

Save items

loading

Related citations in PubMed

Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. [Nat Biotechnol. 2009]
Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes.
Bachovchin DA, Brown SJ, Rosen H, Cravatt BF. Nat Biotechnol. 2009 Apr; 27(4):387-94. Epub 2009 Mar 29.
Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study. [Bioorg Med Chem. 2009]
Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.
Nakai R, Salisbury CM, Rosen H, Cravatt BF. Bioorg Med Chem. 2009 Feb 1; 17(3):1101-8. Epub 2008 Mar 8.
High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. [BMC Biotechnol. 2005]
High-throughput kinase assays with protein substrates using fluorescent polymer superquenching.
Rininsland F, Stankewicz C, Weatherford W, McBranch D. BMC Biotechnol. 2005 May 31; 5:16. Epub 2005 May 31.
Review Molecular diversity of hydroxamic acids: part II. Potential therapeutic applications. [Mini Rev Med Chem. 2003]
Review Molecular diversity of hydroxamic acids: part II. Potential therapeutic applications.
Lou B, Yang K. Mini Rev Med Chem. 2003 Sep; 3(6):609-20.
Review Activity based chemical proteomics: profiling proteases as drug targets. [Curr Drug Discov Technol. 2008]
Review Activity based chemical proteomics: profiling proteases as drug targets.
Heal WP, Wickramasinghe SR, Tate EW. Curr Drug Discov Technol. 2008 Sep; 5(3):200-12.

See reviews... See all...

Cited by 2 PubMed Central articles

Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. [Nat Biotechnol. 2009]
Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes.
Bachovchin DA, Brown SJ, Rosen H, Cravatt BF. Nat Biotechnol. 2009 Apr; 27(4):387-94. Epub 2009 Mar 29.
Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9. [J Leukoc Biol. 2009]
Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9.
MacLauchlan S, Skokos EA, Meznarich N, Zhu DH, Raoof S, Shipley JM, Senior RM, Bornstein P, Kyriakides TR. J Leukoc Biol. 2009 Apr; 85(4):617-26. Epub 2009 Jan 13.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A profiling platform for the identification of selective metalloprotease inhibit...
A profiling platform for the identification of selective metalloprotease inhibitors.
J Biomol Screen. 2008 Apr ;13(4):285-94. Epub 2008 Mar 18 .

PubMed
Isn't there someone to blame?
Isn't there someone to blame?
J Clin Oncol. 2008 Mar 20 ;26(9):1560-1.

PubMed
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihyd...
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
J Clin Oncol. 2008 Mar 20 ;26(9):1489-95.

PubMed
Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography ...
Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
J Clin Oncol. 2008 Mar 20 ;26(9):1459-64.

PubMed
Gliomas: predicting time to progression or survival with cerebral blood volume m...
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Radiology. 2008 May ;247(2):490-8. Epub 2008 Mar 18 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed

Write to the Help Desk